Jocelyn T. Kim
- Virology top 2%
- HIV Research and Treatment 11
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment 5
- HIV/AIDS Research and Interventions 4
- SARS-CoV-2 and COVID-19 Research 3
- COVID-19 Clinical Research Studies 2
- Immunology top 10%
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 3
- Modeling and Simulation top 5%
-
- CAR-T cell therapy research 2
Jocelyn T. Kim
21 papers receiving 877 citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Virology 379
- Infectious Diseases 296
- Immunology 330
- Modeling and Simulation 50
- Public Health, Environmental and Occupational Health 152
Countries citing papers authored by Jocelyn T. Kim
This map shows the geographic impact of Jocelyn T. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn T. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn T. Kim more than expected).
Fields of papers citing papers by Jocelyn T. Kim
This network shows the impact of papers produced by Jocelyn T. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn T. Kim. The network helps show where Jocelyn T. Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jocelyn T. Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 7 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 1 | |
| 8 | 2022 | 23 | |
| 9 | 2021 | 105 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 19 | |
| 12 | 2020 | 38 | |
| 13 | 2019 | 107 | |
| 14 | 2018 | 9 | |
| 15 | 2017 | 11 | |
| 16 | 2016 | 9 | |
| 17 | 2016 | 37 | |
| 18 | 2016 | 13 | |
| 19 | 2012 | 12 | |
| 20 | Cell-to-cell spread of HIV permits ongoing replication despite antiretroviral therapybreakdown → | 2011 | 418 |
About Jocelyn T. Kim
Jocelyn T. Kim is a scholar working on Virology, Infectious Diseases and Immunology, having authored 24 papers that have together received 892 indexed citations. Recurring topics across this work include HIV Research and Treatment (11 papers), Immune Cell Function and Interaction (8 papers), HIV/AIDS drug development and treatment (5 papers), HIV/AIDS Research and Interventions (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), T-cell and B-cell Immunology (3 papers), CAR-T cell therapy research (2 papers) and COVID-19 Clinical Research Studies (2 papers). The work is most often cited by research in Virology (379 citations), Infectious Diseases (296 citations) and Immunology (330 citations). Jocelyn T. Kim has collaborated with scholars based in United States, China and Poland. Frequent co-authors include David Baltimore, Alex Sigal, Alejandro B. Balazs, Avi Mayo, E. Dekel, Ron Milo, James R. Heath, Michael T. Leonard, Jessica K. Wang and Owen N. Witte. Their work appears in journals such as Nature Communications, Cell Reports Medicine, Journal of Visualized Experiments, PLoS ONE and Nature Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.